Category Archives: Business and Investments

Latest From Business and Investments

Biomarkets: Looking For The Hole In The Donut

synthetic biology

This piece by Allan L. Shaw was originally published in Life Science Leader. The biopharma sector has enjoyed increased market success over the last few years. And while some may be tempted to bask in the optimistic “bio-euphoria,” others question whether the industry might be in the midst of a market bubble. What led to this current period of biopharma success, despite the industry’s inherent risks (e.g. scientific, clinical, regulatory, and commercial)? Several factors contributed Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Politicking Biopharma Delays Cures

US Capitol Building

Forbes’ Matthew Herper ran a guest post from Robert Nelsen, cofounder and managing director of ARCH Venture Partners, which addresses the challenges our industry is currently facing amid the continued need for biomedical innovation. Read it here.

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , ,

Warning: Don’t Let Bio-Euphoria Distract You from Being Disciplined

DNA

This piece by Allan L. Shaw was originally published in Life Science Leader. We currently in a period I call “bio-euphoria,” in which the biopharmaceutical industry is experiencing growth in almost every area from market performance to patient-focused legislation. In parallel to this positive momentum, there has also been a notable shift in management and operational strategy by Big Pharma companies in an attempt to keep evolving with the market. These companies are taking creative Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Discover Trends and Investment Opportunities at the BIO Investor Forum

hyde pier

The 2015 BIO Investor Forum in San Francisco is shaping up to be a must-attend event for private equity and public investors, research analysts, and industry executives focused on investment and business development opportunities in the life sciences. The Forum will include candid fireside chats between biopharma CEOs, analysts, and other industry experts. Come hear about recent company successes, what keeps the C-suite up at night, and where the industry’s leading companies are headed in 2016. Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Investment Landscape in Brazil

Rio de Janeiro, Brazil

Brazil has been at the forefront of biotech news recently, with China announcing plans to invest $250B and the recently signed Joint Communique with the U.S. government reaffirming their commitment to strengthening traditional ties, expand trade, and investment cooperation. Brazil is now one of the most attractive and promising biotech markets in the world—human health, agribusiness, raw materials and environmental—and investing in Brazil has become a new priority. Rather than leave innovation financing solely to Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,